经纬恒润(688326) - 2025 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2025 was ¥1,555,430,609.51, representing a year-over-year increase of 2.40%[2] - The total profit for the period was ¥6,668,016.63, while the net profit attributable to shareholders was ¥11,918,415.04, showing significant improvement compared to a net loss of ¥75,046,008.44 year-to-date[2] - The basic and diluted earnings per share for the quarter were both ¥0.11, a recovery from a loss of ¥0.67 year-to-date[2] - Total operating revenue for the first three quarters of 2025 reached ¥4,463,802,946.49, an increase of 26% compared to ¥3,546,024,524.10 in the same period of 2024[17] - The net loss for the first three quarters of 2025 was ¥73,585,467.05, an improvement from a net loss of ¥407,313,181.09 in the same period of 2024[18] - The total comprehensive loss for the first three quarters of 2025 was ¥74,382,985.99, compared to a loss of ¥406,827,023.05 in 2024, showing a significant improvement[18] - The basic and diluted earnings per share for the first three quarters of 2025 were both -¥0.67, compared to -¥3.56 in the same period of 2024[18] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥313,070,704.77, indicating ongoing challenges in cash generation[2] - Cash inflow from operating activities for the first three quarters of 2025 was approximately $4.47 billion, up from $3.03 billion in the same period of 2024, representing a year-over-year increase of about 47.9%[20] - The net cash flow from operating activities was negative $313.07 million in 2025, an improvement compared to negative $874.72 million in 2024[20] - Cash inflow from investment activities increased to approximately $1.33 billion in 2025 from $723.31 million in 2024, marking an increase of about 84.4%[22] - The net cash flow from investment activities was negative $676.50 million in 2025, compared to negative $941.59 million in 2024, indicating a reduced cash outflow[22] - Cash inflow from financing activities rose to approximately $1.11 billion in 2025, up from $631.11 million in 2024, reflecting an increase of about 76%[22] - The net cash flow from financing activities was positive $293.21 million in 2025, contrasting with a negative $1.05 million in 2024[22] - The ending cash and cash equivalents balance for 2025 was approximately $670.01 million, down from $1.38 billion in 2024[22] - The total cash outflow from operating activities was approximately $4.79 billion in 2025, compared to $3.90 billion in 2024, indicating an increase of about 22.7%[20] - The company reported a cash inflow of $68.27 million from tax refunds in 2025, compared to $54.90 million in 2024, showing an increase of about 24.3%[20] Assets and Liabilities - Total assets increased to ¥9,705,296,037.48, reflecting a growth of 3.17% compared to the end of the previous year[3] - Current assets decreased to ¥5,574,861,243.38 from ¥5,839,257,413.18, representing a decline of about 4.53%[12] - Cash and cash equivalents were reported at ¥740,910,978.84, down from ¥1,505,689,965.94, indicating a significant decrease of approximately 50.8%[11] - Accounts receivable totaled ¥1,702,396,513.15, a decrease from ¥1,830,447,902.79, which is a reduction of about 7%[11] - Inventory increased to ¥1,898,630,474.88 from ¥1,482,217,071.41, marking a growth of approximately 28.14%[12] - The company's total liabilities increased to ¥5,641,874,498.07 in 2025 from ¥5,131,028,389.81 in 2024, marking an increase of about 9.9%[15] - The total liabilities increased to ¥5,574,861,243.38, compared to the previous period, indicating a rise in financial obligations[12] - The total equity attributable to shareholders decreased to ¥3,942,144,927.20 in 2025 from ¥4,183,518,680.54 in 2024, a decline of approximately 5.8%[15] Research and Development - Research and development expenses totaled ¥258,504,172.92 for the quarter, accounting for 16.62% of operating revenue, a decrease of 3.9 percentage points year-over-year[3] - The company experienced a reduction in R&D investment by 15.71% year-to-date, totaling ¥797,128,467.79[2] - Research and development expenses for the first three quarters of 2025 were ¥632,830,758.16, down from ¥791,038,271.11 in 2024, indicating a reduction of about 20%[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 6,719, with no preferred shareholders[9] - The company has not reported any changes in the participation of major shareholders in margin financing and securities lending activities during the reporting period[11]